UCB (Euronext: UCB), is a global biopharmaceutical manufacturer heaquartered in Brussels. It focuses on novel therapeutic solutions for patients with severe diseases treated by specialists, particularly in the fields of central nervous system disorders (including epilepsy), inflammatory disorders (including allergy) and oncology.